SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (905)7/9/1997 2:42:00 PM
From: margie   of 6136
 
John, Welcome to this thread and thanks for your contributions. It didn't take you long to figure out David S. Five year old Aaron, who was born HIV positive, and his father must be grateful to companies like Aguouron that have developed drugs for children, and that went to bat so that Aaron could receive Viracept, even though they could not afford it (Life, July 7). The market share for children with AIDS is small and there is not as much incentive for drug companies to develop a pediatric version. Didn't Agouron also say they would make the drug available for those who could not afford it (after they got FDA approval).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News